Purple Book product · Reference 351(a)
Winrho Sd, Winrho Sdf Liquid, Winrho Sdf Lyophilized
Rho(D) Immune Globulin Intravenous (Human)
Apr 02, 1996
Approved
Reference 351(a)
License type
Disc
Marketing
None
Listed patents
Sourced from the FDA Purple Book · verified Jul 02, 2026
Key dates
Approval
Approval date of this BLA submission.
Apr 02, 1996
30 yr 9 mo ago
Orphan exclusivity ends
7-year orphan-drug exclusivity window.
Mar 24, 2002
24 yr 8 mo ago
Today
Pharmaceutical detail
Strength
600IU
Dosage form
For Injection
Route
Intravenous
Presentation
Vial
Center
CBER
License number
2098
Product number
006
Submission type
Original
Supplement number
0
Change type
Not listed
Reference product family
View full familyThis is the reference (originator) product. No biosimilars or interchangeables reference it in the Purple Book yet.
17 additional BLA records for this product (other strengths or presentations) are in the same reference family.
Patent list
No patent-list records were published for this product. The Purple Book patent list reflects the statutory patent exchange under the BPCIA and is not exhaustive.
Source provenance
- advanced-searchAdvanced Search · Jul 02, 2026
- monthly-downloadMonthly download · Jul 02, 2026
Change history
- v6Jul 02, 2026
- v5Jul 02, 2026
- v4Jul 02, 2026
- v3Jul 02, 2026
- v2Jul 02, 2026
Frequently asked questions
Does Winrho Sd, Winrho Sdf Liquid, Winrho Sdf Lyophilized have approved biosimilars?
No 351(k) biosimilars or interchangeable biosimilars referencing Winrho Sd, Winrho Sdf Liquid, Winrho Sdf Lyophilized are listed in the FDA Purple Book yet.
What is Winrho Sd, Winrho Sdf Liquid, Winrho Sdf Lyophilized's BLA number?
Winrho Sd, Winrho Sdf Liquid, Winrho Sdf Lyophilized is licensed under BLA 103649, held by Kamada Ltd..
When was Winrho Sd, Winrho Sdf Liquid, Winrho Sdf Lyophilized approved by the FDA?
Winrho Sd, Winrho Sdf Liquid, Winrho Sdf Lyophilized was approved by the FDA on Apr 02, 1996.
Related FDA reference tools
- FDA Orange BookApproved drugs, generics, therapeutic-equivalence codes, patents, and exclusivity.
- FDA BiosimilarsThe list of FDA-approved biosimilars and interchangeable biosimilars, by reference product.
- 510(k) Predicate DatabaseSearch FDA 510(k) clearances and map predicate-device lineage.
- FDA 483 & Inspection DatabaseFDA Form 483 observations and inspection records by firm, date, and citation.

